Avsnittsbeskrivning
Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!
Dr. Chris Aiken opens this episode with a sentence that could change your prescribing. The add-ons most of us reach for in treatment-resistant depression — bupropion, mirtazapine, buspirone, even stimulants — have failed their large randomized trials. Unanimously. "California rocket fuel" went down in three of them. Meanwhile the treatments with real evidence behind them, like TMS, lithium, and pramipexole, almost never show up in the chart before a patient reaches him.
If that name…
Webbplats: rss.com

